CORC

在结果中检索

CORC

浏览/检索结果: 共48条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
AAV-delivered IL-21 activates CD8+T-cells to clear HBV replicon plasmid and cccDNA in mice 会议论文
作者:  Deng, Qiang;  Shen, Zhongliang;  Liu, Jing;  Wu, Jingwen;  Zhu, Yuanfei
收藏  |  浏览/下载：62/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05
BTLA expression contributes to HBV-related acute-on-chronic liver failure morbidity and mortality by inducing CD4+T-cell exhaustion 会议论文
作者:  Su, Zhijun;  Yu, Xueping;  Yang, Feifei;  Mao, Richeng;  Zhu, Haoxiang
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05
Inhibition of hepatitis B virus replication by FAM176A via activation of PI3K-AKT-mTOR signaling pathway 会议论文
作者:  Yu, Jie;  Shen, Zhongliang;  Zhang, Jiming;  Xie, Youhua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Intrahepatic transcriptional profiling of chronic hepatitis B patients during interferon-alpha treatment 会议论文
作者:  Li, Ning;  Yu, Kangkang;  Dong, Minhui;  Wu, Feizhen;  Zhang, Jiming
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Multi-task learning for location prediction with deep multi-model ensembles 会议论文
作者:  Zhang, Rui;  Guo, Jiming;  Jiang, Hongbo;  Xie, Peng;  Wang, Chen
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace